A 58-year-old man with type 2 diabetes mellitus on metformin monotherapy presents with persistent hyperglycemia (FBS 180 mg/dL, PPBS 240 mg/dL). Regarding the addition of a second agent, all of the following statements about DPP-4 inhibitors are true EXCEPT:

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.